A significant investment in Weill Cornell's leading precision medicine program by Overseer Israel Englander and his wife Caryl will expand the scope of the institution's approach to understanding and treating disease through therapies customized to patients' unique genetic profiles.
Latest news from The Englander Institute for Precision Medicine:
The use of genetic data could fundamentally change how we treat disease.
Precision medicine can offer more tailored treatment options for patients.
This year may just be the year of precision medicine – a term that’s buzzing on health blogs and in research journals. Precision techniques, proponents say, could change the face of medicine forever.
On January 30, 2015, President Obama unveiled the details of the Administration's Precision Medicine Initiative, a bold new research effort to revolutionize the ways in which we improve health and treat disease. (Watch here). Dr. Mark A. Rubin, Director of the Institute for Precision Medicine, was in attendance at this by invitation only event.